drugset / Trial / NCT04511845
A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Phase I, open-label, multi-center study
Timeline
- Start
- 2020-09-10
- Primary completion
- 2026-09-30
- Completion
- 2026-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SPYK04 | Unknown | — | — |
Indications
No indication recorded.